SavedAdd your journal

Journals / International Archives of Medical Research / 2026 / Volume: 10 Issue: 1

A Renal Cell Carcinoma Case Presented w ith Spinal Cord Compression

Zuhat Urakci
Ogur Karhan
Senar Ebinc
Nadiye Akdeniz
Yasin Sezgin
Mehmet Kucukoner
Muhammet Ali Kaplan
Abdurrahman İsikdogan
Pages
—
Publication Date
2018-06-15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Renal cell cancer should be remembered in the differential diagnosis of spinal metastases whena primary tumor is sought.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Renal cell cancer constitutes about 3% of all cancers and is usually seen at advanced age.Approximately 18% of cases are metastatic at the time of diagnosis.
📊
Key Findings & Data:Bone metastases have an average incidence of 30%, of which 15% occur in spinal column.
💡
Conclusion & Impact:Renal cell cancer should be remembered in the differential diagnosis of spinal metastases whena primary tumor is sought.
🔬Design:Case Report
📍Scope:Comprehensive Sample
⚙️Variables:Renal cell cancer · spinal cord compression

Abstract

Renal cell cancer constitutes about 3% of all cancers and is usually seen at advanced age.Approximately 18% of cases are metastatic at the time of diagnosis. Bone metastases have an average incidence of 30%, of which 15% occur in spinal column. Spinal metastases may causepain, bone fractures, neurological deficits due to nerve compression, and hypercalcemia. The treatment of spinal metastases currently involves surgery, radiotherapy, interventional radiological methods, and systemic therapies. Here, we report a patient examined for low back pain and neurological deficit due to spinal metastases, who was detected to have a renal cell cancer as the primary tumor. Renal cell cancer should be remembered in the differential diagnosis of spinal metastases whena primary tumor is sought.

🔖

Cite This Article

Urakci, Z., Karhan, O., Ebinc, S., Akdeniz, N., Sezgin, Y., Kucukoner, M., Kaplan, M. A., İsikdogan, A. (2018). A Renal Cell Carcinoma Case Presented w ith Spinal Cord Compression. International Archives of Medical Research, Volume: 10 Issue: 1. https://ajindex.com/articles/1493214

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. J. Ferlay, F. Bray, P. Pisani, D. Parkin, Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5, IARCPress, Lyon, 2004.
  2. Eble J.N.,Weltgesundheitsorganisation, International Agency for Research on Cancer, éditeurs. Pathology and genetics of tumours of the urinary system and male genital organs: IARC Press; 2004. 359 p.
  3. J.J. Patard, E. Leray, A. Rodriguez, N. Rioux-Leclercq, F. Guille, B. Lobel, Correlation between symptom graduation, tumor characteristics and survival in renal cell carcinoma, Eur. Urol. 44 (2) (2003) 226–232.
  4. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62(1):1029.
  5. J.M. Kozlowski, Management of distant solitary recurrence in the patient with renal cancer. Contralateral kidney and other sites, The Urol. Clin. North Am.21 (4) (1994) 601–24.
  6. Bianchi, M., Sun, M., Jeldres, C., Shariat, S.F., Trinh, Q.-D., Briganti, A., et al., 2012. Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann. Oncol. 23 (January (4)),97380.
  7. Althausen P, Althausen A, Candace Jennings L, Mankin HJ. Prognostic factors and surgical treatment of osseous metastas es secondary to renal cell carcinoma.Cancer,1997;80:1103–9.
  8. Mehdi Borni, Anis Abdehedi, Brahim Kammoun, Firas Jarraya, Mohamed Zaher Boudawara, A first spinal metastasis manifestation of a renal cell carcinoma: A case report and review of the literatüre Urology Case Reports 20 (2018) 78–79.
  9. B. Beuselinck, S. Oudard, O. Rixe, P. Wolter, A. Blesius, J. Ayllon, et al., Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib, Ann. Oncol. 22 (4) (2010) 794–800.
  10. Motzer, R. et al. Kidney cancer, version 2.2017, NCCN clinical practice guidelines in oncology. J. Natl Compr.Canc. Netw.15, 804–834 (2017).
  11. Wood, S. L. & Brown, J. E. Skeletal metastasis in renal cell carcinoma: current and future management options.Cancer Treat. Rev. 38, 284–291 (2012).
  12. Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomized trial. Lancet 2005; 366: 643–8.
  13. D.A. Swanson, W.L. Orovan, D.E. Johnson, G. Giacco, Osseous metastases secondary to renal cell carcinoma, Urology 18 (6) (1981) 556–561.
  14. Beuselinck, B., Oudard, S., Rixe, O., Wolter, P., Blesius, A., Ayllon, J., et al., 2011. Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 22 (April (4)),794800.
  15. Yuasa, T. et al. Treatment outcome and prognostic factors in renal cell cancer patients with bone metastasis. Clin. Exp. Metastasis 28, 405–41 (2011).
  16. R.J. Motzer, J. Bacik, M. Mazumdar, Prognostic factors for survival of patients with stage IV renal cell carcinoma, Clin. Canc. Res. 10 (18) (2004) 6302S–3S.
  17. James Langdon, Adam Way, Samuel Heaton, Jason Bernard, Sean Molloy, The management of spinal metastases from renal cell carcinoma,Ann R Coll Surg Engl 2009; 91: 649–652